AMY EVERHART: Open Payments
NPI 1376187427 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 49 payments from 8 companies in 2025. Trend: 2023 $401 · 2024 $767 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 12 | $261 |
| ABBVIE INC. | 17 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $218 |
| Axsome Therapeutics, Inc. | 8 | $216 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Alkermes, Inc. | 2 | $42 |
| Lundbeck LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: ZURZUVAE, VRAYLAR, CAPLYTA, Auvelity, TRINTELLIX, ARISTADA, REXULTI.
Industry payments across OH — which companies pay providers there.
